Details for Patent: 9,603,853
✉ Email this page to a colleague
Which drugs does patent 9,603,853 protect, and when does it expire?
Patent 9,603,853 protects QELBREE and is included in one NDA.
This patent has seventeen patent family members in seven countries.
Summary for Patent: 9,603,853
Title: | Formulations of viloxazine |
Abstract: | Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed. |
Inventor(s): | Vieira; Michael L. (Gaithersburg, MD), Huang; Austin B. (N. Potomac, MD), Bhatt; Padmanabh P. (Rockville, MD) |
Assignee: | Supernus Pharmaceuticals, Inc. (Rockville, MD) |
Application Number: | 15/157,549 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,603,853
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964-001 | Apr 2, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ⤷ Try a Trial | ||||
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964-002 | Apr 2, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ⤷ Try a Trial | ||||
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964-003 | Apr 2, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,603,853
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013217013 | ⤷ Try a Trial | |||
Australia | 2017206245 | ⤷ Try a Trial | |||
Australia | 2019216707 | ⤷ Try a Trial | |||
Australia | 2020233746 | ⤷ Try a Trial | |||
Canada | 2864088 | ⤷ Try a Trial | |||
European Patent Office | 2812074 | ⤷ Try a Trial | |||
European Patent Office | 4233915 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |